Microvascular Thrombosis in the Hepatic Vein of a Patient with Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by complement-mediated hemolysis, venous thrombosis, and bone marrow failure. In May 2003, a 33-year-old man was admitted to a hospital with right hypochondralgia and fever. He had a history of aplastic anemia. The patient’s diagnosis of diffuse microvessel thrombosis in the hepatic vein due to an unknown cause was derived from the findings of a contrast-enhanced computed tomography examination of the abdominal region, angiographic evaluation of abdominal vessels, and pathohistologic examination of a liver biopsy sample. The patient was subsequently treated with warfarin. The abdominal pain and fever continued, however, and anemia gradually appeared. In April 2004, the patient was referred to our hospital to examine the cause of the thrombosis. On admission, slight anemia and a low serum haptoglobin level were observed. A flow cytometry evaluation of CD55 and/or CD59, CD59, and CD48 expression in erythrocytes, granulocytes, and monocytes, respectively, showed that the respective proportions of negative populations were 5.6%, 97.1%, and 96.2%. The patient then received a diagnosis of aplastic anemia/PNH syndrome, which had caused the hemolytic anemia and thrombosis, although no hemoglobinuria had been observed during his clinical course. This patient is, to our knowledge, the first reported case of a PNH patient with thrombosis present only in hepatic microvessels and not in hepatic large vessels, in spite of the presence of few hemolytic events.

[1]  K. Ikeda,et al.  The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone. , 2007, Experimental hematology.

[2]  H. Noji,et al.  Heterogeneity in the Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria (PNH) Syndromes and Expansion Mechanism of a PNH Clone , 2006, International journal of hematology.

[3]  K. Ikeda,et al.  High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome , 2006, Leukemia.

[4]  H. Mitsuya,et al.  Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. , 2006, Blood.

[5]  S. Hall,et al.  Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan , 2004, Medicine.

[6]  C. O'keefe,et al.  Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis. , 2004, Experimental hematology.

[7]  P. Kamath,et al.  The Budd-Chiari syndrome. , 2004, The New England journal of medicine.

[8]  C. Rutherford,et al.  CASE REPORT: Paroxysmal Nocturnal Hemoglobinuria With No Evidence of Hemolysis Presenting as Budd-Chiari Syndrome , 2000, Digestive Diseases and Sciences.

[9]  S. Richards,et al.  Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). , 2003, Blood.

[10]  H. Liebman,et al.  Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. , 2003, Thrombosis research.

[11]  W. Rosse New insights into paroxysmal nocturnal hemoglobinuria , 2001, Current opinion in hematology.

[12]  J. Ray,et al.  Paroxysmal Nocturnal Hemoglobinuria and the Risk of Venous Thrombosis: Review and Recommendations for Management of the Pregnant and Nonpregnant Patient , 2000, Pathophysiology of Haemostasis and Thrombosis.

[13]  T. Nagasawa,et al.  Inhibition of complement‐mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low‐molecular weight heparin , 2000, British journal of haematology.

[14]  Y. Hasegawa,et al.  Complement‐induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH , 1999, British journal of haematology.

[15]  D. Fleming,et al.  Identical twin marrow transplantation for venous thrombosis in paroxysmal nocturnal hemoglobinuria; long-term complete remission as assessed by flow cytometry , 1998, Bone Marrow Transplantation.

[16]  C. Miller,et al.  Resolution of Budd‐Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria , 1996, British journal of haematology.

[17]  T. Ortel,et al.  Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. , 1993, Blood.

[18]  Teizo Fujita,et al.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria , 1993, Cell.

[19]  P. Heller,et al.  Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. , 1992, Chest.

[20]  N. E. Hansen,et al.  The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. , 1992, Blood.

[21]  H. Ohto,et al.  Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes , 1991, British journal of haematology.

[22]  S. Butler,et al.  The kidneys in paroxysmal nocturnal hemoglobinuria. , 1981, Blood.

[23]  R. Rhodes,et al.  Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) with particular reference to progressive, diffuse hepatic venous thrombosis. , 1972, Series haematologica.